Stanford University completed a pioneering study combining wearable sensors with advanced molecular testing to monitor patients receiving CAR-T cell therapy, an innovative cancer treatment. The research aimed to detect dangerous side effects like cytokine release syndrome and brain toxicity earlier than traditional methods. Eleven cancer patients with lymphoma and leukemia wore continuous monitoring devices while undergoing treatment. Researchers collected real-time physiological data alongside comprehensive blood and molecular analyses to create detailed health profiles. This integrated approach could revolutionize how doctors manage severe treatment complications, potentially saving lives through earlier intervention and more precise care.
